These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1845828)

  • 1. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb.
    Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J
    Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
    Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
    Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
    Tsai CH; Glaser R
    Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
    Tsai CH; Williams MV; Glaser R
    Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies.
    Dölken G; Hecht T; Röckel D; Hirsch FW
    Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
    Takada K; Fujiwara S; Yano S; Osato T
    Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
    Thorley-Lawson DA; Geilinger K
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
    J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220.
    Qualtiere LF; Decoteau JF; Hassan Nasr-el-Din M
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():535-43. PubMed ID: 2434608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
    Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
    Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
    Hoffman GJ; Lazarowitz SG; Hayward SD
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
    Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
    Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
    Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
    Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
    Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
    Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
    Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
    Thorley-Lawson DA
    Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.